Jeffery P Struewing
机构: Program Director, National Institutes of Health
每年引用次数
引用次数
引用: 44,546
H-指数: 67
I10-指数 : 119
出版物: 154
BRCA1 mutations in young women with breast cancer
JefferyP. Struewing , RobertE. Tarone , LawrenceC. Brody , FrederickP. Li
The Lancet 347 ( 9013) 1493
44
1996
Clinical Trials of the Column Disc Peritoneal Catheter (Lifecath Tm)
Stephen R. Ash , Jeffrey D. Struewing
Peritoneal Dialysis International 3 ( 2) 77 -80
10
1983
Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Tucker Ma , Struewing Jp , Ponder Ba , Watson P
Journal of The National Cancer Institute Monographs ( 17) 33 -35
163
1995
Secular changes in case mix of SCI patients at Montebello.
Cadigan Da , Struewing Jp , Lefkowitz A , Epstein Rs
Maryland medical journal 37 ( 4) 291
1988
Predictors of rehabilitation outcome among patients with SCI.
Cadigan Da , Struewing Jp , Lefkowitz A , Epstein Rs
Maryland medical journal 38 ( 6) 489
2
1989
Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium
Ruth M. Pfeiffer , Joni L. Rutter , Mitchell H. Gail , Jeffery Struewing
Genetic Epidemiology 22 ( 1) 94 -102
30
2002
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
Susan L Neuhausen , Sylvie Mazoyer , Lori Friedman , Michael Stratton
American journal of human genetics 58 ( 2) 271 -271
313
1996
255 Atelosteogenesis Type 11 Is Caused by Mutations in the Diastrophic Dysplasia Sufate-Transporter Gene
Susan L Neuhausen , Adelaide Caligo Offit , Lisa Cannon-Albright , Fergus Couch Weber
The American Journal of Human Genetics 58 ( 2)
1996
Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination.
D. M. Musher , J. E. Groover , J. M. Rowland , D. A. Watson
Clinical Infectious Diseases 17 ( 1) 66 -73
154
1993
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel.
G Hirsh-Yechezkel , A Chetrit , F Lubin , E Friedman
Gynecologic Oncology 89 ( 3) 494 -498
52
2003
Performance of high-throughput DNA quantification methods
Kashif A Haque , Ruth M Pfeiffer , Michael B Beerman , Jeff P Struewing
BMC Biotechnology 3 ( 1) 20 -20
86
2003
AN EPIDEMIC OF RESPIRATORY COMPLAINTS EXACERBATED BY MASS PSYCHOGENIC ILLNESS IN A MILITARY RECRUIT POPULATION
JEFFERY P. STRUEWING , GREGORY C. GRAY
American Journal of Epidemiology 132 ( 6) 1120 -1129
27
1990
Automated Detection of Prevalent Mutations in BRCA1 and BRCA2 Genes, Using a Fluorogenic PCR Allelic Discrimination Assay
MOHAMMAD R. ABBASZADEGAN , JEFFERY P. STRUEWING , KEVIN M. BROWN , JIM V. SNIDER
Genetic Testing 1 ( 3) 171 -180
18
1997
HRCA-I gene mutation is commonly identified among women with early-onset breast cancer and is particularly common in Jewish women
Langston AA , Malone KE , Thompson JD , Daling JR
Advances in Anatomic Pathology 3 ( 4) 248
1996
EPIDEMIOLOGIC AND GENETIC-CHARACTERISTICS OF 10 FAMILIES WITH BRCA1 MUTATIONS
JP STRUEWING , LC BRODY , RG KASE , TA GIAMBARRESI
AMERICAN JOURNAL OF HUMAN GENETICS 57 ( 4) 284 -284
1995
PREDICTED UPTAKE AND IMPACT OF GENETIC TESTING IN INHERITED BREAST-OVARIAN CANCER FAMILIES
JP STRUEWING , CE LERMAN , R KASE , T GIAMBARRESI
AMERICAN JOURNAL OF HUMAN GENETICS 53 ( 3) 766 -766
1993
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families
Steven A Narod , Deborah Ford , Peter Devilee , Rosa B Barkardottir
American journal of human genetics 56 ( 1) 254 -254
385
1995
Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics
Montserrat Garcia-Closas , Per Hall , Heli Nevanlinna , Karen Pooley
PLoS Genetics 4 ( 4) e1000054
321
2008
Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
Terri H. Beaty , David J. Kaufman , Jeffery P. Struewing
Cancer Epidemiology, Biomarkers & Prevention 12 ( 10) 1045 -1052
10
2003